Display options
Cite
Yeh JS, Oh SJ, Hsueh CM. Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin. 2016;32(5):570-577doi: 10.6515/acs20151013g.
Yeh, J. S., Oh, S. J., & Hsueh, C. M. (2016). Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiologica Sinica, 32(5), 570-577. https://doi.org/10.6515/acs20151013g
Yeh, Jong Shiuan, et al. "Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries." Acta Cardiologica Sinica vol. 32,5 (2016): 570-577. doi: https://doi.org/10.6515/acs20151013g
Yeh JS, Oh SJ, Hsueh CM. Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin. 2016 Sep;32(5):570-577. doi: 10.6515/acs20151013g. PMID: 27713606; PMCID: PMC5052476.
Copy Download .nbib Format: NLM
Share it on

Acta Cardiol Sin. 2016 Sep;32(5):570-577. doi: 10.6515/acs20151013g.

Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries.

Acta Cardiologica Sinica

Jong Shiuan Yeh, Seung Jin Oh, Chun Mei Hsueh

Affiliations

  1. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, New York, USA; ; Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University; ; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University Taipei, Taiwan.
  2. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, New York, USA; ; Division of Cardiology, Department of Internal Medicine, National Health Insurance Corporation, Ilsan Hospital, Seoul, The Republic of Korea.
  3. Department of Ophthalmology, Taipei Medical University Hospital; ; Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

PMID: 27713606 PMCID: PMC5052476 DOI: 10.6515/acs20151013g

Abstract

BACKGROUND: We aimed to describe the frequency of vascular inflammatory reactions with second generation drug eluting stents (DES) compared to first generation DES, and analyze the impact on inflammation and neointimal proliferation in a porcine coronary model.

METHODS: A total of 26 stents (7 multi-link VISION, 6 CYPHER, 6 TAXUS and 7 XIENCE V) were deployed in the coronary arteries of 10 domestic swine for 28 days, after which each stent was harvested and processed (divided into 8 or 9 segments) for histomorphometric analysis.

RESULTS: A total of 202 histological segments [146 DES and 56 bare metal stents (BMS)] were included in this study. The mean neointimal thickness was significantly reduced in the DES group compared to the BMS group. The DES group had higher injury scores (DES = 0.99 ± 0.79 versus BMS = 0.67 ± 0.44, p < 0.004), inflammatory scores (DES = 2.09 ± 1.54 versus BMS = 0.64 ± 0.98, p < 0.001) and presence of para-strut granulomas (DES = 35% versus BMS = 2%, p < 0.001). In logistic regression analysis, the presence of para-strut granulomas correlated with an area of stenosis > 50% (RR: 6.11, 95% CI: 2.97 to 12.59, p = 0.001). In the DES group, the second generation stents had a lower neointimal area (XIENCE V: 1.64 ± 0.90 mm

CONCLUSIONS: Second generation DES had a lower incidence of vascular inflammatory reactions compared to first generation DES. This biological phenomenon appears to influence the patterns of neointimal formation.

Keywords: Drug eluting stent; Porcine coronary artery; Vascular inflammation reaction

References

  1. Catheter Cardiovasc Interv. 2003 Dec;60(4):515-23 - PubMed
  2. Coron Artery Dis. 1999;10(1):9-14 - PubMed
  3. J Am Coll Cardiol. 1998 Jan;31(1):224-30 - PubMed
  4. J Am Coll Cardiol. 2006 Jan 3;47(1):175-81 - PubMed
  5. Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455 - PubMed
  6. J Biomater Sci Polym Ed. 1992;4(1):35-44 - PubMed
  7. Cardiology. 1999;92 (3):171-7 - PubMed
  8. JACC Cardiovasc Interv. 2009 Dec;2(12 ):1190-8 - PubMed
  9. J Am Coll Cardiol. 2005 Mar 15;45(6):954-9 - PubMed
  10. JACC Cardiovasc Interv. 2011 Oct;4(10):1057-66 - PubMed
  11. JAMA. 2005 Sep 14;294(10 ):1215-23 - PubMed
  12. Vasc Health Risk Manag. 2008;4(1):31-8 - PubMed
  13. JACC Cardiovasc Interv. 2014 Jan;7(1):20-8 - PubMed
  14. J Am Coll Cardiol. 2008 Jul 29;52(5):333-42 - PubMed
  15. J Am Coll Cardiol. 1992 Feb;19(2):267-74 - PubMed
  16. Circulation. 2001 Oct 23;104(17):1996-8 - PubMed
  17. Heart. 2003 Feb;89(2):133-8 - PubMed
  18. Contact Dermatitis. 2008 Feb;58(2):101-6 - PubMed
  19. Circulation. 2002 Oct 1;106(14):1867-73 - PubMed
  20. EuroIntervention. 2012 Jun 20;8(2):250-7 - PubMed
  21. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1157-65 - PubMed
  22. JACC Cardiovasc Interv. 2012 Nov;5(11):1141-9 - PubMed
  23. Circulation. 2009 Jul 14;120(2):141-9, 1-2 - PubMed
  24. Eur Heart J. 2012 Mar;33(5):606-13 - PubMed
  25. Circulation. 2014 Jan 14;129(2):211-23 - PubMed
  26. JACC Cardiovasc Interv. 2009 Jul;2(7):583-93 - PubMed
  27. Circulation. 2004 Oct 19;110(16):2498-505 - PubMed
  28. Circulation. 2004 Feb 17;109 (6):701-5 - PubMed
  29. Catheter Cardiovasc Interv. 2006 Jul;68(1):97-103 - PubMed
  30. Lancet. 2010 Jan 16;375(9710):201-9 - PubMed
  31. Circ J. 2014;78(11):2665-73 - PubMed

Publication Types